American Journal of Infectious Diseases and Microbiology
ISSN (Print): 2328-4056 ISSN (Online): 2328-4064 Website: Editor-in-chief: Maysaa El Sayed Zaki
Open Access
Journal Browser
American Journal of Infectious Diseases and Microbiology. 2021, 9(3), 71-82
DOI: 10.12691/ajidm-9-3-1
Open AccessArticle

Concomitant Infection with Leishmania donovani and Plasmodium berghei Causes Pro-inflammatory Polarization Resulting in Malaria Exacerbation in BALB/c Mice

Rebeccah. M. Ayako1, 2, , Joshua. M. Mutiso1, John. C. Macharia2, David Langoi3 and Lucy Ochola2

1Department of Zoological Sciences, Kenyatta University, Nairobi, Kenya

2Department of Tropical and Infectious Diseases, Institute of Primate Research, Nairobi, Kenya

3Department of Animal Science, Institute of Primate Research, Nairobi, Kenya

Pub. Date: July 29, 2021

Cite this paper:
Rebeccah. M. Ayako, Joshua. M. Mutiso, John. C. Macharia, David Langoi and Lucy Ochola. Concomitant Infection with Leishmania donovani and Plasmodium berghei Causes Pro-inflammatory Polarization Resulting in Malaria Exacerbation in BALB/c Mice. American Journal of Infectious Diseases and Microbiology. 2021; 9(3):71-82. doi: 10.12691/ajidm-9-3-1


Malaria and visceral leishmaniasis coexist in the same geographical regions. However, dual co-infection with parasites causing these diseases and their impact on public health is poorly documented. Interactions between these parasites may play a role in disease outcome. The present study set out to evaluate the clinical and immunological parameters following Leishmania donovani and Plasmodium berghei co-infection in BALB/c mice. Mice were divided into four groups; L. donovani- only, L. donovani-P. berghei, P. berghei- only and naïve. Body weight, parasite burden, total IgG, IFN-γ and IL-4 responses were determined. To determine the survival rate, four mice were used from each group. Tissues for histological analysis were taken from spleen, liver and brain. Results indicated significant differences in body weight (P<0.0001), L. donovani parasite load (P< 0.0001), L. donovani IgG (P< 0.0001), P. berghei parasitemia (P= 0.0222), P. berghei IgG (P= 0.002), IFN-γ (P<0.0001) and IL-4 (P<0.0001) in dual-infected mice. There was no correlation between L. donovani parasite load and IgG responses in single or dual infections, while there was a positive relationship of P. berghei parasitemia and IgG responses in the dual infection group only. Plasmodium berghei had the highest mortality rate compared to L. donovani- only and L. donovani- P. berghei infected mice groups. Histological analyses showed enlarged red and white pulps and pathological changes in the spleen, liver and brain tissues which were less pronounced in co-infected group. We conclude that L. donovani and P. berghei co-infection reduces disease severity and these changes seem to correlate with variation in serum IgG and cytokines (IFN-γ and IL-4). Therefore, the study recommends the importance of inclusion of early screening of malaria in Visceral Leishmaniasis patients in regions where malaria is co- endemic.

disease severity co-infection cytokines IgG Leishmania donovani Plasmodium berghei BALB/c mice

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


Figure of 9


[1]  Gedda MR, Singh B, Kumar D, Singh AK, Madhukar P, Upadhyay S, et al. Post kala-azar dermal leishmaniasis: A threat to elimination program. 14, PLoS Neglected Tropical Diseases. Public Library of Science; 2020. 1-25.
[2]  Boelaert M, Criel B, Leeuwenburg J, Van Damme W, Le Ray D, Van Der Stuyft P. Visceral leishmaniasis control: A public health perspective. Vol. 94, Transactions of the Royal Society of Tropical Medicine and Hygiene. Royal Society of Tropical Medicine and Hygiene; 2000. 465-71.
[3]  Kevric I, Cappel MA, Keeling JH. New World and Old World Leishmania Infections: A Practical Review. Vol. 33, Dermatologic Clinics. W.B. Saunders; 2015. p. 579-93.
[4]  WHO | Leishmaniasis. WHO. 2018.
[5]  Bennink S, Kiesow MJ, Pradel G. The development of malaria parasites in the mosquito midgut. Cell Microbiol. 2016; 18(7): 905-18.
[6]  Prevention C-C for DC and. CDC - Malaria - Malaria Worldwide - Impact of Malaria. 2020.
[7]  Mbacham WF, Ayong L, Guewo-Fokeng M, Makoge V. Current situation of malaria in Africa. In: Methods in Molecular Biology. Humana Press Inc.; 2019. 29-44.
[8]  Tripathi P, Singh V, Naik S. Immune response to Leishmania: paradox rather than paradigm. FEMS Immunol Med Microbiol. 2007;30]; 51(2): 229-42.
[9]  Dayakar A, Chandrasekaran S, Kuchipudi S V., Kalangi SK. Cytokines: Key determinants of resistance or disease progression in visceral leishmaniasis: Opportunities for novel diagnostics and immunotherapy. Vol. 10, Frontiers in Immunology. Frontiers Media S.A.; 2019. 670.
[10]  The “World malaria report 2019” at a glance.
[11]  Mutiso JM, Macharia JC, Taracha E, Gicheru MM. Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops). J Biomed Res. 2012; 26(1): 8-16.
[12]  Khosravi A, Asadollahy E, Ghafourian S, Sadeghifard N, Mohebi R. Synthesis and evaluation of monoclonal antibody against Plasmodium falciparum merozoite surface antigen 2. Asian Pac J Trop Med. 2013 Oct 1; 6(10): 798-803.
[13]  Habluetzel A, Pinto B, Tapanelli S, Nkouangang J, Saviozzi M, Chianese G, et al. Effects of Azadirachta indica seed kernel extracts on early erythrocytic schizogony of Plasmodium berghei and pro-inflammatory response in inbred mice. Malar J; 18(1): 35.
[14]  Verma S, Mandal A, Ansari MY, Kumar A, Abhishek K, Ghosh AK, et al. Leishmania donovani inhibitor of serine peptidases 2 mediated inhibition of lectin pathway and upregulation of C5aR signaling promote parasite survival inside host. Front Immunol. 2018; 9.
[15]  Martins YC, Werneck GL, Carvalho LJ, Silva BPT, Andrade BG, Souza TM, et al. Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol. Malar J. 2010; 9(1).
[16]  Yamaguchi H, Shen J. Histological Analysis of Neurodegeneration in the Mouse Brain. In: Methods in molecular biology (Clifton, NJ). 2013; 91-113.
[17]  Khayeka-Wandabwa C, Kutima HL, Nyambati VC, Ingonga J, Oyoo-Okoth E, Karani LW, et al. Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni. Parasites and Vectors. 2013; 6(1): 1-10.
[18]  Basir R, Rahiman SF, Hasballah K, Chong W, Talib H, Yam M, et al. Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iran J Parasitol 2012; 7(4): 62-74.
[19]  Lakkavaram A, Lundie RJ, Do H, Ward AC, de Koning-Ward TF. Acute Plasmodium berghei Mouse Infection Elicits Perturbed Erythropoiesis With Features That Overlap With Anemia of Chronic Disease. Front Microbiol. 2020; 11.
[20]  Lafuse WP, Story R, Mahylis J, Gupta G, Varikuti S, Steinkamp H, et al. Leishmania donovani Infection Induces Anemia in Hamsters by Differentially Altering Erythropoiesis in Bone Marrow and Spleen. van Zandbergen G, editor. PLoS One. 2013; 8(3): e59509.
[21]  Pinna RA, Silva-dos-Santos D, Perce-da-Silva DS, Oliveira-Ferreira J, Villa-Verde DMS, De Luca PM, et al. Malaria-Cutaneous Leishmaniasis co-infection: Influence on disease outcomes and immune response. Front Microbiol. 2016.
[22]  Kumar R, Bumb RA, Salotra P. Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica. FEMS Immunol Med Microbiol. 2009; 57(3): 239-46.
[23]  Ozbilge H, Aksoy N, Gurel MS, Yazar S. IgG and IgG subclass antibodies in patients with active cutaneous leishmaniasis. J Med Microbiol. 2006 Oct; 55(10): 1329-31.
[24]  Goodman AL, Forbes EK, Williams AR, Douglas AD, De Cassan SC, Bauza K, et al. The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. Sci Rep. 2013; 3(1): 1-13.
[25]  Long CA, Zavala F. Immune Responses in Malaria. Cold Spring Harb Perspect Med. 2017; 7(8).
[26]  Gowda DC, Wu X. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria, Frontiers in immunology. NLM (Medline); 2018. p. 3006.
[27]  Kumar R, Singh N, Gautam S, Singh OP, Gidwani K, Rai M, et al. Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis. Carvalho EM, editor. PLoS Negl Trop Dis. 2014; 8(10): e3198.
[28]  Wu X, Gowda NM, Kawasawa YI, Gowda DC. A malaria protein factor induces IL-4 production by dendritic cells via PI3K–Akt–NF-B signaling independent of MyD88/ TRIF and promotes Th2 response. J Biol Chem. 2018; 293(27): 10425-34.
[29]  Loeuillet C, Bañuls AL, Hide M. Study of Leishmania pathogenesis in mice: Experimental considerations. Vol. 9, Parasites and Vectors. BioMed Central Ltd.; 2016.
[30]  Dehghan H, Oshaghi MA, Mosa-Kazemi SH, Abai MR, Rafie F, Nateghpour M, et al. Experimental study on Plasmodium berghei, Anopheles stephensi, and BALB/c mouse system: Implications for malaria transmission blocking assays. Iran J Parasitol. 2018; 13(4): 549-59.
[31]  Salguero FJ, Garcia-Jimenez WL, Lima I, Seifert K. Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: A time-course study. Parasites and Vectors. 2018; 11(1): 1-9.
[32]  Pereira CG, Silva ALN, de Castilhos P, Mastrantonio EC, Souza RA, Romão RP, et al. Different isolates from Leishmania braziliensis complex induce distinct histopathological features in a murine model of infection. Vet Parasitol. 2009 Nov 12; 165(3-4): 231-40.
[33]  Santana CC, de Freitas LAR, Oliveira GGS, dos-Santos WLC. Disorganization of spleen compartments and dermatitis in canine visceral leishmaniasis. Surg Exp Pathol. 2019; 2(1): 14.
[34]  Santana CC, Vassallo J, De Freitas LAR, Oliveira GGS, Pontes-De-Carvalho LC, Dos-Santos WLC. Inflammation and structural changes of splenic lymphoid tissue in visceral leishmaniasis: A study on naturally infected dogs. Parasite Immunol. 2008; 30(10): 515-24.
[35]  Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006; 37(2): 550-5.